The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting

Journal of the American Academy of Nurse Practitioners

Volumn 21, Issue 3, 2009, Pages 173-178

  Neira, Claudia P ^a,b   Hartig, Margaret ^a   Cowan, Patricia A ^a   Velasquez Mieyer, Pedro A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UT LifeDOC   (United States)

Author keywords

Diabetes in primary care; Diabetes prevention; Diabetes risk; Hispanics and diabetes; Impaired glucose metabolism; Metabolic syndrome

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; BLOOD; BODY MASS; COMORBIDITY; FEMALE; GLUCOSE INTOLERANCE; HISPANIC; HUMAN; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORGANIZATION AND MANAGEMENT; PHYSICAL EXAMINATION; PILOT STUDY; PREVALENCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADULT; BODY MASS INDEX; CHOLESTEROL; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HISPANIC AMERICANS; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PHYSICAL EXAMINATION; PILOT PROJECTS; PREVALENCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 62349114819     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2008.00380.x     Document Type: Article

References (26)

1. Appel, S. J., Jones, E. D. Kennedy-Malone, L 2004). Central obesity and the metabolic syndrome: Implications for primary care providers. Journal of the American Academy of Nurse Practitioners, 16, 335 342.
2. Benjamin, S. M., Valdez, R., Geiss, L. S., Rolka, D. B. Narayan, K. M 2003). Estimated number of adults with prediabetes in the US in 2000: Opportunities for prevention. Diabetes Care, 26, 645 649.
3. Centers for Disease Control and Prevention 2003). Prevalence of diabetes and impaired fasting glucose in adults - United States, 1999-2000. MMWR Morbidity and Mortality Weekly Report, 52, 833 837.
4. Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Eberhardt, M. S., Flegal, K. M., Engelgau, M. M., et al 2006). Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population. Diabetes Care, 29, 1263 1268.
5. Diabetes Prevention Program Research Group 2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393 403.
6. Festa, A., D'Agostino, R., Jr., Howard, G., Mykkanen, L., Tracy, R. P. Haffner, S. M 2000). Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS). Circulation, 102, 42 47.
7. Ford, E. S., Wayne, H. Giles, W. H 2003). Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. Journal of the American Medical Association, 287, 356 359.
8. Haffner, S. M 2006). The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. American Journal of Cardiology, 97 (2A 3A 11A.
9. Hanley, A. J., Karter, A. J., Williams, K., Festa, A., D'Agostino, R. B., Jr., Wagenknecht, L. E., et al 2005). Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: The Insulin Resistance Atherosclerosis Study. Circulation, 112, 3713 3721.
10. Houston, M. C., Basile, J., Bestermann, W. H., Egan, B., Lackland, D., Hawkins, R. G., et al 2005). Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. American Journal of the Medical Sciences, 329, 276 291.
11. Kahn, R., Buse, J., Ferrannini, E. Stern, M 2005). The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 28, 2289 2304.
12. Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A., et al 2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393 403.
13. Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program 2005). Diabetes Care, 28, 2472 2479.
14. Lorenzo, C., Okoloise, M., Williams, K., Stern, M. P. Haffner, S. M 2003). The metabolic syndrome as predictor of type 2 diabetes: The San Antonio Heart Study. Diabetes Care, 26, 3153 3159.
15. Lorenzo, C., Williams, K., Hunt, K. J. Haffner, S. M 2006). Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: The San Antonio Heart Study. Diabetes Care, 29, 625 630.
16. Meigs, J. B., Wilson, P. W., Nathan, D. M., D'Agostino, R. B., Sr., Williams, K. Haffner, S. M 2003). Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes, 52, 2160 2167.
17. Narayan, K. M., Boyle, J. P., Thompson, T. J., Sorensen, S. W. Williamson, D. F 2003). Lifetime risk for diabetes mellitus in the United States. Journal of the American Medical Association, 290, 1884 1890.
18. National Institute of Health 1998). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - The evidence report. National Institutes of Health, National Heart, Lung, and Blood Institute, September 1998. Retrieved December 3, 2007, from www.nhlbi.nih.gov/guidelines/obesity/obgdlns.htm.
19. Ridker, P. M., Buring, J. E., Cook, N. R. Rifai, N 2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation, 107, 391 397.
20. Sanchez, C. P., Velazquez, O., Berber, A., Lara-Esqueda, A., Tapia-Conyer, R. James, W 2003). Anthropometric cutoff points for predicting chronic diseases in the Mexican National Health Survey 2000. Obesity Research, 11, 442 451.
21. Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O'Reilly, D. S., Haffner, S. M., et al 2003). Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 108, 414 419.
22. Thang, S., H., Williams, K., Gonzalez-Villalpando, C., Lean, M. F. Haffner, S. M 2002). Prospective study of c-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetic Study. Diabetes Care, 25, 2016 2021.
23. Tuomilehto, J., Lindstrom, J., Eriksson, J. G., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P., et al 2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 344, 1343 1350.
24. Wilson, P. W., D'Agostino, R. B., Parise, H., Sullivan, L. Meigs, J. B 2005). Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation, 112, 3066 3072.
25. World Health Organization 1998). Obesity: Preventing and managing the global epidemic. Report of a World Health Organization Consultation on Obesity, Geneva, June 3-5, 1997. Geneva, Switzerland : Author.
26. World Health Organization 2007). Global database on body mass index. Retrieved December 3, 2007, from http://www.who.int/bmi/index.jsp?introPage= intro-3.html